ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

フロキサシリン

Flucloxacillin

HCID 21319
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
5250-39-5
標準SMILES
Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O
InChIKey
UIOFUWFRIANQPC-JKIFEVAISA-N
分子式
C19H17ClFN3O5S
平均分子量
453.9 g/mol
単同位体質量
453.0561477

概要

Flucloxacillin is a penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of a flucloxacillin(1-).

名称と識別子

優先名称
Flucloxacillin
IUPAC
(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
現地名
フロキサシリン
英語名
Flucloxacillin
分子式
C19H17ClFN3O5S
分子量
453.87

名称と別名

FlucloxacillinFLOXACILLIN5250-39-5flucloxacilinaFlucloxacillineFlucloxacillinumBRL 2039Fluorochloroxacillin3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillinflucloxacillinaBRL-2039(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
名称をさらに表示
フロキサシリンフルクロキサシリン(2S,5R,6R)-6-[3-(2-クロロ-6-フルオロフェニル)-5-メチル-1,2-オキサゾール-4-アミド]-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-2-カルボン酸6α-[[[3-(2-クロロ-6-フルオロフェニル)-5-メチルイソオキサゾール-4-イル]カルボニル]アミノ]ペニシラン酸フルオキサシリンペンプルス6α-[[[3-(2-クロロ-6-フルオロフェニル)-5-メチル-4-イソオキサゾリル]カルボニル]アミノ]ペニシラン酸(2S,5β)-6α-[3-(2-クロロ-6-フルオロフェニル)-5-メチルイソオキサゾール-4-イルカルボニルアミノ]-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-2β-カルボン酸FlopenFlucilCulpenFK 900FlupenPenplusFloxapenStaphylex
ABBOFLOXSTAPHLIPENCHEBI:5098DTXSID802305643B2M34G2V(2S,5R,6R)-6-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S(2alpha,5alpha,6beta))6-(3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid

物性

構造計算による物性補完中

XLogP
2.6
極性表面積
138 Ų
水素結合供与体数
2
水素結合受容体数
8
回転可能結合数
4
重原子数
30
形式電荷
0
複雑度
758

実験および物理化学的性質

Drugs · 4 件

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

LogP · 2 件

3.2

2.58

Solubility5.45e-02 g/L
Human Drugs · 2 件

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Penicillins

Access group antibiotics

Physical DescriptionSolid

物理化学的性質

沸点
677.3 · 677.3±55.0 °C(Predicted)
比重(密度)
1.59 · 1.59±0.1 g/cm3(Predicted)
溶解性
soluble in Methanol, Water
酸解離定数(Pka)
2.7 · pKa 2.7 (Uncertain)
外見
Solid
色
White
CAS データベース
5250 · 5250-39-5(CAS DataBase Reference)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Other Safety InformationIMAP assessments - 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2.alpha.,5.alpha.,6.beta.)]-: Environment tier I assessment

毒性情報

Drug Induced Liver Injury · 5 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Flucloxacillin

DILI Positive

oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

化学と産業

薬理情報

ATC Code · 5 件

J01CF05

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

J01CF02

Pharmacodynamics · 1 件

Flucloxacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Flucloxacillin has <i>in vitro</i> activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Flucloxacillin results from the inhibition of cell wall synthesis and is mediated through flucloxacillin binding to penicillin binding proteins (PBPs). Flucloxacillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Mechanism of Action · 1 件

By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, flucloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that flucloxacillin interferes with an autolysin inhibitor.

Biological Half-Life0.75–1 hour
Metabolism/Metabolites · 2 件

Hepatic.

Flucloxacillin has known human metabolites that include 6-[[3-(2-Chloro-6-fluorophenyl)-5-(hydroxymethyl)-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and ExcretionBioavailability is 50–70% following oral administration.

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
5250-39-5
PubChem CID
21319
DTXSID
DTXSID8023056
ChEMBL
CHEMBL222645
ChEBI
CHEBI:5098
UNII
43B2M34G2V
EC Number
226-051-0
Nikkaji
J8.825K
Cellular Locations
Cytoplasm

用途と製造

UsesUse (kg) in Switzerland (2009): >250
応用分野 · 3 件

説明Chemically this is 3(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl penicillin; this differs from dicloxacillin only by the substitution of a fluorine for a chlorine atom (Sutherland et al., 1970). It comes as oral capsules of 250 and 500 mg, as a suspension of 25 and 50 mg/ml, and in an injectable formulation of 500 mg and 1 g.

使用Antibacterial.

一般的な説明Flucloxacillin was synthesized by Beecham Research Laboratories in 1962 as a penicillinase-stable and orally active semisynthetic penicillin. It shows almost the same activity as dicloxacillin, and it has slightly higher serum and tissue concentrations than dicloxacillin. This drug has been used to treat pyoderma, sepsis, and postoperative infections as well as ear and nose, respiratory tract, and other infections caused by Staphylococcus and Streptococcus, including benzylpenicillin-resistant strains.

上流・下流製品情報

上流原料

塩化スルフィニル水酸化ナトリウムナトリウムメトキシドアセト酢酸メチル塩素6-アミノペニシラン酸2-クロロ-6-フルオロベンズアルデヒドオキシム

補足説明

定義ChEBI: A penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain.